RE:RE:RE:RE:RE:RE:RE:RE:RE:so far so goodAzaak,
MC and BT before him have been trying to sell this company for more than 15 years.
Trouble is, of the forty(ish) tirals they've run, 80% of them failed and the few that showed promise were borderline.
There is nothing to sell.
MC's only hope for personal gain at this time is to somehow raise another year's worth of cash and continue to collect his salary. The only way he can do this is to over-promise and deceptively suggest that a P3 trial in BC is close (hint, it's not going to happen) and also claim that Roche is collaborating with ONC on a P3 in Pancreatic cancer due to begin enrollment this summer (hint, it's not going to happen).
MC can continue this game indefinitely so long as there are "investors" like you who are willing to part with thier money. It's been working for 25 years, so why not 25 more?
Failed trials include but are not limtied to:
Lung
Prostrate
Ovarian
Melanoma
Head and Neck
Bladder
Brain
Sarcoma
Multple Myeloma
Youth - unspecified solid tumours
Note, many of the above are multiple failed incarnations with different variations of disease and/or combo therapy.
Marginal results include:
Breast
Pancreatic
Colorectal
The only indication that truly has even the slightest chance of ever progressing to a P3 is pancreatic.
But this will never happen under MC's leadership because he does not have the skills to manage a large P3 and neither does he have the ability to successfully partner with a BP.